The antitussive activity of δ-opioid receptor stimulation in guinea pigs

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 803-809

  Kotzer, Charles J ^a   Hay, Douglas W P ^a   Dondio, Giulio ^a   Giardina, Giuseppe ^a   Petrillo, Paola ^a   Underwood, David C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUSSIVE AGENT; BETA FUNALTREXAMINE; BRL 52974; CODEINE; DELTA OPIATE RECEPTOR; DEXTROMETHORPHAN; HYDROCODONE; ISOQUINOLINE DERIVATIVE; MU OPIATE RECEPTOR; NALOXONE; NORBINALTORPHIMINE; PHENANTHRENE DERIVATIVE; PYRIDINE DERIVATIVE; RECEPTOR SUBTYPE; RIMCAZOLE; SB 227122; SB 244525; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COUGHING; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; GUINEA PIG; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; CARBAZOLES; CELL LINE; CHO CELLS; CLONING, ORGANISM; CODEINE; COUGH; CRICETINAE; DEXTROMETHORPHAN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GUINEA PIGS; HUMANS; HYDROCODONE; LEVALLORPHAN; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PROTEIN BINDING; PYRIDINES; PYRROLES; PYRROLIDINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0033965196     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aiyar N, Baker E, Wu H-L, Nambi P, Edwards RM, Trill JJ, Ellis C and Bergsma DJ (1994) Human AT1 receptor is a single copy gene: Characterization in a stable cell line. Mol Cell Biochem 131:75-86.
2. Baron BM, Siegel BW, Slone AL, Harrison BL, Palfreyman MG and Hurt SD (1991) [3H]-5,7-dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. Eur J Pharmacol 206:149-154.
3. Benfenati F and Guardabasso V (1984) Basic concepts to analyze binding data using personal computers. The "Receptor" program, in Principles and Methods in Receptor Binding (Cattabeni F and Nicosia S eds) pp 41-63, Plenum Press, New York.
4. Braga PC, Fossati A, Vimercati MG, Caputo R and Guffanti EE (1994) Dextrorphan and dextromethorphan: Comparative antitussive effects on guinea pigs. Drugs Exp Clin Res 20:199-203.
5. Callaway JR, King RG and Boura AL (1991) Evidence for peripheral mechanisms mediating the antitussive actions of opioids in the guinea pig. Gen Pharmacol 22:1103-1108.
6. Chen ZR, Irvine RJ, Somogyi AA and Bochner F ( 1991) Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 48:2165-2171.
7. Cheng YC and Prusoff WH (1973) Relationship between the inhibition constant (Ki) an the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Coltro CC and Clarke GD (1995) Effects of highly selective kappa-opioid agonists on EEG power spectra and behavioral correlates in conscious rats. Pharmacol Biochem Behav 51:611-616.
9. Dionne RA, Dobbins KR and Hargreaves KM (1991) Evaluation of a kappa opioid agonist, spiradoline, in comparison to morphine and placebo in the oral surgery model. Clin Pharmacol Ther 49:183.
10. Dondio G, Ronzoni S and Petrillo P (1997) Non-peptide delta opioid agonists and antagonists. Exp Opin Ther Patents 7:1075-1098.
11. Eddy NB, Friebel H, Hahn K and Hennies H (1969) Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine-mechanisms, methodology and evaluation. Bull WHO 40:425-454.
12. Forsberg K, Karlsson JA, Theodorsson E, Lundberg JM and Persson CGA (1988) Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm Pharmacol 1:33-39.
13. Forsberg K, Karlsson JA, Zackrisson C and Persson CGA (1992) Selective inhibition of cough and bronchoconstriction in conscious guinea pigs. Respiration 59:72-76.
14. Giardina G, Clarke GD, Grugni M, Sbacchi M and Vecchietti V (1995) Central and peripheral analgesic agents: Chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes. Farmaco 50:405-418.
15. Hayes AG, Skingle M and Tyers MB (1985) Effect of B-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H. J. Pharm Pharmacol 37:841-843.
16. Kamei J, Iwamoto Y, Misawa M and Kasuya Y (1993a) Effects of rimcazole, a specific antagonist of sigma sites, on the antitussive effects of non-narcotic antitussive drugs. Eur J Pharmacol 242:209-211.
17. Kamei J, Iwamoto Y, Misawa M, Nagase H and Kasuya Y (1993b) Antitussive effect of beta-endorphin is mediated by mu-opioid receptors, but not by kappa-or epsilon-opioid receptors. Eur J Pharmacol 233:251-254.
18. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H and Kasuya Y (1993c) Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats. Eur J Pharmacol 249:161-165.
19. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H and Kasuya Y (1994a) Antitussive effect of dihydroetorphine in mice. Eur J Pharmacol 260:257-259.
20. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H and Kasuya Y (1994b) Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists. Eur J Pharmacol 251:291-294.
21. Kamei J, Iwamoto Y, Suzuki T, Nagase H, Misawa M and Kaauya Y (1993d) Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice. Eur J Pharmacol 234:117-120.
22. Kamei J, Tanihara H and Kasuya Y (1990) Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats. Eur J Pharmacol 187: 281-286.
23. Kamei J, Tanihara H and Kasuya Y (1991) Modulation of mu-mediated antitussive activity in rats by a delta agonist. Eur J Pharmacol 203:153-156.
24. Kamei J, Tanihara H and Kasuya Y (1992) Modulation of kappa-mediated antitussive activity in rats by a delta-agonist. Res Comm Chem Pathol Pharmacol 76: 375-378.
25. Karlsson JA, Lanner AS and Persson CG (1990) Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J Pharmacol Exp Ther 252:863-868.
26. Knapp RJ, Malatynska E, Fang L, Li K, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ and Roeske WR (1994) Identification of a human delta opioid receptor: Cloning and expression. Life Sci 54:L463-L469.
27. Lalloo UG, Barnes PJ and Chung KF (1995) Captopril inhibits tachyphylaxis to citric acid-induced cough in guinea pigs (Abstract). Am J Respir Crit Care Med 151: A110.
28. Laude EA, Higgins KS and Morice AH ( 1993) A comparative study of the effects of citric acid, capsaicin and resiniferatoxin on the cough challenge in guinea-pig and man. Pulm Pharmacol 6:171-175.
29. Maguire PA, Perez JJ, Tsai NF, Rodriguez L, Beatty MF, Villar JO, Kamal JJ, Upton C, Casey AF and Loew GJ (1993) Molecular mechanism of delta-selectivity of indole analogs of nonpeptide opioid. Mol Pharmacol 44:1246-1251.
30. Mansson E, Bare L and Yang D ( 1994) Isolation of a human kappa opioid receptor cDNA from placenta. Biochem Biophys Res Comm 202:1431-1437.
31. Petrillo PAP, Dondio G, Gatti PA, Graziani D, Manzoni C and Ronzoni S (1998) In vitro characterization of new potent and selective pyrrolomorphinans. 29th Meeting of the International Narcotics Research Conference; Jul 20-25; Garmisch-Partenkirchen, Germany.
32. Piirila P and Sovijarvi ARA (1995) Objective assessment of cough. Eur Respir J 8:1949-1956.
33. Portoghese PS, Larson DL, Sultana M and Takemori AE (1992) Opioid agonist and antagonist activities of morphindoles related to naltrindole. J Med Chem 35:4325-4329.
34. Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, Cowell SM, Slate CA, Ehlert FJ, Roeske WR and Yamamura HI (1999) The delta-opioid receptor: Molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51:503-532.
35. Rapaka RS and Porreca F (1991) Development of delta opioid peptides as nonaddicting analgesics. Pharmacol Res 8:1-8.
36. Rogers H, Hayes AG, Birch PJ, Traynor JR and Lawrence AJ (1990) The selectivity of the opioid antagonist, naltrindole for delta-opioid receptors. J Pharm Pharmacol 42:358-359.
37. Scheideler MA and Zukin RS (1990) Reconstitution of solubilized delta-opiate receptor binding sites in lipidic vesicles. J Biol Chem 265:15176-15182.
38. Simonin F, Befort K, Gaveriaux-Ruff C, Matthes H, Nappey V, Lannes B, Micheletti G and Kieffer B (1994) The human delta-opioid receptor: Genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol Pharmacol 46:1015-1021.
39. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA and Uhl GR (1994) Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 338:217-222.
40. Zenz M and Willweber-Strumpf A (1993) Opiophobia and cancer pain in Europe. Lancet 341:1075-1076.